This is a preview of subscription content, log in via an institution to check access.
Reference
Benucci M, et al. Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis. Clinical and Experimental Rheumatology : 27 May 2013. Available from: URL: http://dx.doi.org/6269
Rights and permissions
About this article
Cite this article
Abatacept good choice for RA treatment in Italy. PharmacoEcon Outcomes News 682, 4 (2013). https://doi.org/10.1007/s40274-013-0533-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0533-0